INVESTOR
RELATIONS

Investing in Africa, for Africa

Every decision we make is inspired and driven by the purpose to ‘Care For Every Life’. We’re constantly seeking new and innovative solutions to achieve that goal.

investor right

ANNOUNCEMENTS

Download Document

AGM Management Presentation 2024

Download Document

Post AGM Notice 2024

Download Document

Qcil 2024 AGM Notice

Download Document

Qcil Proxy form

Download Document

Qcil AGM 2024 Resolutions - Explanatory Notes

Download Document

Qcil Financial Performance FY23-FY24

Download Document

Qcil Announcement - CS Resignation

Download Document

Qcil Change Of Name Announcement

Download Document

Qcil Interim Dividend Announcement

Download Document

QCIL 2023 Post EGM Notice

Download Document

QCIL EGM 2023 Questions

Download Document

Announcement Of Changes On The Board Of Directors

Download Document

Notice Of CQCIL EGM

Download Document

Proxy Form - CQCIL EGM

Download Document

CiplaQCIL Profit Warning

Download Document

CiplaQCIL Public Notice - Conclusion Of Share Purchase By Africa Capitalworks SSA 3 From Meditab Holdings Ltd And Cipla EU Ltd

Download Document

CiplaQCIL 2023 AGM Notice

Download Document

FAQ On The Proposed Sale Of Shares By Meditab Holding Limited And Cipla (EU) Ltd To Africa Capitalworks SSA

Download Document

Cautionary Announcement

Download Document

CiplaQCIL Post AGM Notice

Download Document

CiplaQCIL AGM Notice

Download Document

H1 FY21-22 Interim Results Announcement

Download Document

CiplaQCIL Post AGM Notice

Download Document

CiplaQCIL AGM Notice

Download Document

Proxy Form - CiplaQCIL AGM Notice

Download Document

Cautionary Statement

Download Document

Acquisition Of The Human Care Business

Download Document

CiplaQCIL Post AGM Notice

Download Document

CiplaQCIL AGM Notice

PERFORMANCE

Download Document

Full Audited Annual Financial Statements

2023 / 2024

Download Document

Half Year Interim Financial Results

2023 / 2024

Download Document

Audited Financial Statements

2022 / 2023

Download Document

Half Year Interim Financial Results

2022 / 2023

Download Document

Audited Financial Statements

2021 / 2022

Download Document

Annual Financial Results

2021 / 2022

Download Document

Audited Financial Statement

2020 / 2021

Download Document

Half Year Interim Financial Results

2020 / 2021

Download Document

Audited Financial Statement

2019 / 2020

ANNUAL REPORTS

Download Document

Annual Report

2023 / 2024

Download Document

Annual Report

2022 / 2023

Download Document

Annual Report

2021 / 2022

Download Document

Annual Report

2020 / 2021

Download Document

Annual Report

2019 / 2020

Download Document

Annual Report

2018 / 2019

CORPORATE GOVERNANCE

Download Document

Code of Conduct

Download Document

QCIL Dividend Policy

Download Document

Whistleblower Policy

AGM Q&A’s

Download Document

AGM 2023 Questions & Answers

Download Document

AGM 2022 Questions & Answers

Download Document

AGM 2021 Questions & Answers

FAQ's

The board did not recommend the issuing of a dividend due to the performance of the Company As and when a dividend is issued, shareholder will be informed of how the dividend will be paid.

To increase your shares, please contact the stockbroker who opened your securities depository account to guide you on how you can purchase the additional shares.

The Company's annual financial statements are available on the Company website

This is dependent on the number of shares you hold and the prevailing share price.

The value of shares of any listed company can rise and fall according to supply and demand and the views of the market on a company's performance at any one time.

The Annual financial statements and AGM Notice and Post AGM Notice have been sent through email and have also been uploaded on the Company’s website. Shareholders can send an email to shareholder@ciplaqcil.co.ug for assistance with any information you might need.

The current board is comprised of eleven members and by any standard it is considered as a large board. The size and complexity of the business requires a wide range of skills and each member currently on the Board possesses a critical skill that is currently needed to deliver our vision of manufacturing home grown affordable quality medicines made in Africa for Africa.

The Nomination and Remunerations Committee annually reviews the composition of the Board and determines the optimal number in line with the required skills and strategic objectives. The competencies of the board members can be viewed in the Annual Report and the Company website.

The Board is aware of the current gender imbalance and all appointments take into consideration the need to close this gap.

The Company has a diverse range of shareholders and our objective of communication is to ensure information is available to all. A communications strategy has been developed which is focused on ensuring sufficient information is provided to shareholders. Some of the engagement strategies that have been adopted include use of social platforms like Instagram, twitter, shareholder Email and revamping the Company website. The Company will continually come up with mechanisms to enhance shareholder engagement.

The Company took the overdraft to manage the cash flow gap that was created by the debt caused by delay in payment by Zambia.

Some of the funds from the overdraft facility were used to complete the projects that were running in the factory notably, to complete the quality control laboratory, equipping the laboratory adequately and replacing inefficient machinery in order to increase the capacity. Management is in the process of acquiring a loan to substitute the short-term funds with long-term. The objective of this is to match the long-term funds with the long-term capital investments. This will improve the interest costs and also achieve the maturity margin where long term funds are matched with long term expenditure.

The released funds will go a long way to boast the capital and also increase the plant capacity in order to continuously improve the on-time delivery which is one of our strengths.

Questions or comments about your investment?